Euromedis Groupe SA
LSE:0I0L

Watchlist Manager
Euromedis Groupe SA Logo
Euromedis Groupe SA
LSE:0I0L
Watchlist
Price: 6.7 EUR Market Closed
Market Cap: €20m

Relative Value

0I0L price has not been updated for more than 4 years. This may indicate that the stock has been delisted.

The Relative Value of one 0I0L stock under the Base Case scenario is 8.3 EUR. Compared to the current market price of 6.7 EUR, Euromedis Groupe SA is Undervalued by 19%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

0I0L Relative Value
Base Case
8.3 EUR
Undervaluation 19%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

0I0L Competitors Multiples
Euromedis Groupe SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Euromedis Groupe SA
LSE:0I0L
13.4m EUR 0.3 -2.4 -2.9 -3.9
US
Abbott Laboratories
NYSE:ABT
189.8B USD 4.3 29.1 16.7 22.9
US
Intuitive Surgical Inc
NASDAQ:ISRG
171.4B USD 17 59.9 45.4 55.8
US
Stryker Corp
NYSE:SYK
133.2B USD 5.3 41 20.9 25.3
IE
Medtronic PLC
NYSE:MDT
112.8B USD 3.2 24.4 13.5 19.7
US
Boston Scientific Corp
NYSE:BSX
102.9B USD 5.1 35.4 20.8 28
DE
Siemens Healthineers AG
XETRA:SHL
43.3B EUR 1.9 20.5 11.4 16.1
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD 8 45.2 24.9 27.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
46.5B USD 10.8 43.8 31.1 34.4
US
Becton Dickinson and Co
NYSE:BDX
46B USD 2.1 26.1 10.2 17.3
US
Resmed Inc
NYSE:RMD
33.6B USD 6.2 22.6 15.9 17.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Euromedis Groupe SA
LSE:0I0L
Average EV/EBITDA: 21.1
Negative Multiple: -2.9
N/A N/A
US
Abbott Laboratories
NYSE:ABT
16.7
11%
1.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
45.4
23%
2
US
Stryker Corp
NYSE:SYK
20.9
12%
1.7
IE
Medtronic PLC
NYSE:MDT
13.5
8%
1.7
US
Boston Scientific Corp
NYSE:BSX
20.8
18%
1.2
DE
Siemens Healthineers AG
XETRA:SHL
11.4
10%
1.1
US
Edwards Lifesciences Corp
NYSE:EW
24.9
14%
1.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
31.1
11%
2.8
US
Becton Dickinson and Co
NYSE:BDX
10.2
1%
10.2
US
Resmed Inc
NYSE:RMD
15.9
11%
1.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Euromedis Groupe SA
LSE:0I0L
Average EV/EBIT: 26.4
Negative Multiple: -3.9
N/A N/A
US
Abbott Laboratories
NYSE:ABT
22.9
18%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
55.8
25%
2.2
US
Stryker Corp
NYSE:SYK
25.3
16%
1.6
IE
Medtronic PLC
NYSE:MDT
19.7
17%
1.2
US
Boston Scientific Corp
NYSE:BSX
28
26%
1.1
DE
Siemens Healthineers AG
XETRA:SHL
16.1
15%
1.1
US
Edwards Lifesciences Corp
NYSE:EW
27.2
15%
1.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
34.4
12%
2.9
US
Becton Dickinson and Co
NYSE:BDX
17.3
15%
1.2
US
Resmed Inc
NYSE:RMD
17.7
12%
1.5
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett